Chi KN, Armstrong AJ, Krause BJ, Herrmann K, et al. Safety Analyses of the Phase 3 VISION Trial of [(177)Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 2024 Jan 6:S0302-2838(23)03297-9. doi: 10.1016/j.eururo.2023.
PMID: 38185538